Delavirdine Oral Tablet [Rescriptor]
RxNorm 706018
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 706018 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: delavirdine Oral Tablet [Rescriptor].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDF
Semantic Branded Drug Form (SBDF):
Delavirdine Oral Tablet [Rescriptor]
(Atom ID: 12320038)
Patient Education
Delavirdine
Delavirdine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Delavirdine is in a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works by decreasing the amount of HIV in the blood. Although delavirdine does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
[Learn More]
* Please review the disclaimer below.